250 related articles for article (PubMed ID: 32379303)
1. Personalised Adherence Support for Maintenance Treatment of Inflammatory Bowel Disease: A Tailored Digital Intervention to Change Adherence-related Beliefs and Barriers.
Chapman S; Sibelli A; St-Clair Jones A; Forbes A; Chater A; Horne R
J Crohns Colitis; 2020 Oct; 14(10):1394-1404. PubMed ID: 32379303
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
Campos S; Portela F; Sousa P; Sofia C
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
[TBL] [Abstract][Full Text] [Related]
3. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.
Horne R; Parham R; Driscoll R; Robinson A
Inflamm Bowel Dis; 2009 Jun; 15(6):837-44. PubMed ID: 19107771
[TBL] [Abstract][Full Text] [Related]
4. Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease.
Fu N; Jacobson K; Round A; Evans K; Qian H; Bressler B
World J Gastroenterol; 2017 Aug; 23(29):5405-5411. PubMed ID: 28839441
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohn's Disease and Ulcerative Colitis.
Tiao DK; Chan W; Jeganathan J; Chan JT; Perry J; Selinger CP; Leong RW
Inflamm Bowel Dis; 2017 Aug; 23(8):1257-1261. PubMed ID: 28719539
[TBL] [Abstract][Full Text] [Related]
6. Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
Jeganathan J; Lee CH; Rahme A; Tiao DK; Weston C; Dutt S; Magoffin A; Kwan V; Alswaifi A; Katelaris PH; Gaskin KJ; OʼLoughlin EV; Leong RW
Inflamm Bowel Dis; 2017 Jul; 23(7):1065-1070. PubMed ID: 28498154
[TBL] [Abstract][Full Text] [Related]
7. Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.
Gallinger ZR; Rumman A; Nguyen GC
J Crohns Colitis; 2016 Aug; 10(8):892-7. PubMed ID: 26896087
[TBL] [Abstract][Full Text] [Related]
8. Applying a perceptions and practicalities approach to understanding nonadherence to antiepileptic drugs.
Chapman SC; Horne R; Eade R; Balestrini S; Rush J; Sisodiya SM
Epilepsia; 2015 Sep; 56(9):1398-407. PubMed ID: 26215092
[TBL] [Abstract][Full Text] [Related]
9. Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.
Hommel KA; Baldassano RN
J Pediatr Psychol; 2010 Oct; 35(9):1005-10. PubMed ID: 20026567
[TBL] [Abstract][Full Text] [Related]
10. Barriers to oral medication adherence for adolescents with inflammatory bowel disease.
Ingerski LM; Baldassano RN; Denson LA; Hommel KA
J Pediatr Psychol; 2010 Jul; 35(6):683-91. PubMed ID: 19776229
[TBL] [Abstract][Full Text] [Related]
11. Patients' beliefs and attitudes about their treatment for inflammatory bowel disease in Korea.
Kim SB; Kim KO; Jang BI; Kim ES; Cho KB; Park KS; Chung MK; Jeon SW;
J Gastroenterol Hepatol; 2016 Mar; 31(3):575-80. PubMed ID: 26313162
[TBL] [Abstract][Full Text] [Related]
12. Changing adherence-related beliefs about ICS maintenance treatment for asthma: feasibility study of an intervention delivered by asthma nurse specialists.
Chapman SC; Barnes N; Barnes M; Wilkinson A; Hartley J; Piddock C; Weinman J; Horne R
BMJ Open; 2015 Jun; 5(6):e007354. PubMed ID: 26048207
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a medication-adherence tool: study protocol for a randomized controlled trial.
Hilbink M; Lacroix J; Bremer-van der Heiden L; van Halteren A; Teichert M; van Lieshout J
Trials; 2016 Jun; 17(1):274. PubMed ID: 27255080
[TBL] [Abstract][Full Text] [Related]
14. Family Support is Associated with Fewer Adherence Barriers and Greater Intent to Adhere to Oral Medications in Pediatric IBD.
Feldman ECH; Durkin LK; Greenley RN
J Pediatr Nurs; 2021; 60():58-64. PubMed ID: 33618177
[TBL] [Abstract][Full Text] [Related]
15. A Pilot Study Evaluating the Impact of an Adherence-promoting Intervention Among Nonadherent Youth With Inflammatory Bowel Disease.
Maddux M; Ricks S; Delurgio S; Hommel K
J Pediatr Nurs; 2017; 35():72-77. PubMed ID: 28728772
[TBL] [Abstract][Full Text] [Related]
16. The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology.
Hommel KA; Gray WN; Hente E; Loreaux K; Ittenbach RF; Maddux M; Baldassano R; Sylvester F; Crandall W; Doarn C; Heyman MB; Keljo D; Denson LA
Contemp Clin Trials; 2015 Jul; 43():105-13. PubMed ID: 26003436
[TBL] [Abstract][Full Text] [Related]
17. Adherence to Azathioprine/6-Mercaptopurine in Children and Adolescents with Inflammatory Bowel Diseases: A Multimethod Study.
Alsous MM; Hawwa AF; Imrie C; Szabo A; Alefishat E; Farha RA; Rwalah M; Horne R; McElnay JC
Can J Gastroenterol Hepatol; 2020; 2020():9562192. PubMed ID: 32185153
[TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of the Beliefs About Medication Scale in pediatric inflammatory bowel disease.
Thomason MM; Poulopoulos N; Nguyen E; Gumidyala AP; Kahn SA; Greenley RN
J Child Health Care; 2017 Sep; 21(3):253-262. PubMed ID: 29119807
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a self-report measure of practical barriers to medication adherence: The medication practical barriers to adherence questionnaire (MPRAQ).
Chan AHY; Vervloet M; Lycett H; Brabers A; van Dijk L; Horne R
Br J Clin Pharmacol; 2021 Nov; 87(11):4197-4211. PubMed ID: 33486802
[TBL] [Abstract][Full Text] [Related]
20. Barriers to adherence among adolescents with inflammatory bowel disease.
Greenley RN; Stephens M; Doughty A; Raboin T; Kugathasan S
Inflamm Bowel Dis; 2010 Jan; 16(1):36-41. PubMed ID: 19434722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
